Document:

exv10w2

 

Exhibit 10.2

The following executives and key employees have executed the form of Employment Agreement that
follows:

Gary D. Tollefson, M.D., Ph.D., President and Chief Executive Officer

Michael A. Cowley, Ph.D., Chief Scientific Officer

Anthony A. McKinney, Chief Operating Officer

Graham K. Cooper, Chief Financial Officer

Eduardo Dunayevich, M.D., Chief Medical Officer

Ronald P. Landbloom, M.D., Vice President of Medical and Regulatory Affairs

Heather D. Turner, Vice President, General Counsel and Secretary

Carol Baum, Vice President of Commercialization

Walter Piskorski, Vice President of Technical Operations

Franklin P. Bymaster, Vice President of Neuroscience

 

EMPLOYMENT AGREEMENT

     This Employment Agreement (“Agreement”) is entered into as of the                     , by and
between                      (“Executive”) and Orexigen Therapeutics, Inc. (the “Company”) and is contingent
on final approval by the Company’s Board of Directors.

     Whereas, the Company desires to employ Executive to provide personal services to the
Company, and wishes to provide Executive with certain compensation and benefits in return for
Executive’s services; and

     Whereas, Executive wishes to be employed by the Company and provide personal services
to the Company in return for certain compensation and benefits.

     Now, Therefore, in consideration of the mutual promises and covenants contained
herein, it is hereby agreed by and between the parties hereto as follows:

ARTICLE I

DEFINITIONS

     For purposes of the Agreement, the following terms are defined as follows:

1.1 “Board” means the Board of Directors of the Company.

1.2 “Cause” means the occurrence of any of the following events:

     (a) Executive’s conviction of or plea of guilty or nolo contendere to any felony or a crime of
moral turpitude;

     (b) Executive’s willful and continued failure or refusal to follow reasonable instructions of
the                                          and the Chief Executive Officer and/or President of the Company or
reasonable policies, standards and regulations of the Company or its affiliates;

     (c) Executive’s willful and continued failure or refusal to faithfully and diligently perform
the usual, customary duties of his/her employment with the Company or its affiliates;

     (d) Unprofessional, unethical, immoral or fraudulent conduct by Executive;

     (e) Conduct by Executive that materially discredits the Company or any affiliate or is
materially detrimental to the reputation, character and standing of the Company or any affiliate;
or

     (f) Executive’s material breach of the Proprietary Information and Inventions Agreement.

     An event described in Section 1.2(b) through Section 1.2(f) herein shall not be treated as
“Cause” until after Executive has been given written notice of such event, failure or conduct and
Executive fails to cure such event, failure, conduct or breach, if curable, within 30 days from

 

 

such written notice. Failure of the Company to meet financial or performance targets or goals
shall not be deemed to be a breach pursuant to Sections 1.2(b) or 1.2(c) herein.

1.3 “Change in Control” means the occurrence of any of the following events:

     (a) the direct or indirect acquisition by any person or related group of persons (other than
the Company or a person that directly or indirectly controls, is controlled by, or is under common
control with, the Company) of beneficial ownership (within the meaning of Rule 13d-3 of the
Exchange Act) of securities possessing more than 50% of the total combined voting power of the
Company’s outstanding securities pursuant to a tender or exchange offer made directly to the
Company’s shareholders which the Board does not recommend such shareholders to accept;

     (b) a change in the composition of the Board over a period of 36 months or less such that a
majority of the Board members ceases, by reason of one or more contested elections for Board
membership, to be comprised of individuals who either (i) have been Board members continuously
since the beginning of such period, or (ii) have been elected or nominated for election as Board
members during such period by at least a majority of the Board members described in clause (i) who
were still in office at the time such election or nomination was approved by the Board;

     (c) the consummation of any consolidation, share exchange or merger of the Company (i) in
which the stockholders of the Company immediately prior to such transaction do not own at least a
majority of the voting power of the entity which survives/results from that transaction, or (ii) in
which a stockholder of the Company who does not own a majority of the voting stock of the Company
immediately prior to such transaction, owns a majority of the Company’s voting stock immediately
after such transaction; or

     (d) the liquidation or dissolution of the Company or any sale, lease, exchange or other
transfer (in one transaction or a series of related transactions) of all or substantially all the
assets of the Company, including stock held in subsidiary corporations or interests held in
subsidiary ventures.

1.4 “Company” means Orexigen Therapeutics, Inc. or, following a Change in Control, the surviving
entity resulting from such transaction.

1.5 “Constructive Termination” means Executive’s voluntary resignation following:

     (a) a material reduction in the level of responsibility associated with Executive’s employment
with the Company or any surviving entity (other than a change in job title or officer title);

     (b) any reduction in Executive’s level of base salary; or

     (c) a relocation of Executive’s principal place of employment by more than 50 miles (other
than reasonable business travel required as part of the job duties associated with Executive’s
position);

2

 

     provided, and only in the event that, such change, reduction or relocation is effected by the
Company without cause and without Executive’s consent.

1.6 “Covered Termination” means an Involuntary Termination Without Cause or Constructive
Termination that occurs within the one-month period before the effective date of a Change in
Control and the six-month period commencing on the effective date of a Change in Control.

1.7 “Exchange Act” means the Securities Exchange Act of 1934, as amended.

1.8 “Involuntary Termination Without Cause” means Executive’s dismissal or discharge other than for
Cause. The termination of Executive’s employment as a result of Executive’s death or disability
will not be deemed to be an Involuntary Termination Without Cause.

ARTICLE II

EMPLOYMENT BY THE COMPANY

2.1 Position and Duties. Subject to terms set forth herein, the Company agrees to employ Executive
in the position of                      and Executive hereby accepts such employment. Executive shall
serve in an executive capacity and shall perform such duties as are customarily associated with the
position of                      and such other duties as are assigned to Executive by the
                                         of the Company. During the term of Executive’s employment with the Company,
Executive will devote Executive’s best efforts and substantially all of Executive’s business time
and attention (except for vacation periods and reasonable periods of illness or other incapacities
permitted by the Company’s general employment policies or as otherwise set forth in this Agreement)
to the business of the Company.

2.2 Employment at Will. Both the Company and Executive shall have the right to terminate
Executive’s employment with the Company at any time, with or without Cause, upon 30 days’ written
notice. If Executive’s employment with the Company is terminated, Executive will be eligible to
receive severance benefits to the extent provided in this Agreement. If applicable, upon the date
of Executive’s termination of employment with the Company for any reason, Executive shall
immediately resign from the Board and the board of directors or comparable body of every
subsidiary, parent or other affiliated corporation of the Company, and every committee thereof.

2.3 Employment Policies. The employment relationship between the parties shall also be governed by
the general employment policies and practices of the Company, including those relating to
protection of confidential information and assignment of inventions, except that when the terms of
this Agreement differ from or are in conflict with the Company’s general employment policies or
practices, this Agreement shall control.

2.4 Effective Date. The effective date of this agreement shall be the date in which Executive
begins employment with the Company which is anticipated to be                                         .

3

 

ARTICLE III

COMPENSATION AND BENEFITS

3.1 Base Salary. Executive shall receive for services to be rendered hereunder an annual base
salary of $                     (“Base Salary”), payable on the regular payroll dates of the Company.

3.2 Annual Bonus. In addition to the Base Salary, Executive will be eligible for an annual
performance bonus, equal to up to ___% of the Base Salary, and which is 100% based upon the
achievement of the performance goals and objectives to be determined by the compensation committee
of the Board (“Annual Bonus”). Such Annual Bonus shall be evaluated and paid in January of each
year.

3.3 Stock Options. Subject to approval of the Board or the compensation committee of the Board,
Executive shall receive stock options to purchase                      shares of the Company’s common stock
pursuant to the Company’s 2007 Equity Incentive Award Plan (the “2007 Plan”). Any stock options
granted pursuant to this Section 3.3 shall have an exercise price per share equal to the
then-current fair market value per share of the Company’s common stock (as determined pursuant to
the 2007 Plan) on the date the grant is approved by the Board or the compensation committee of the
Board. Such stock options shall be incentive stock options to the extent permitted under Section
422 of the Internal Revenue Code of 1986, as amended (the “Code”). Subject to Section 4.2, 25% of
the shares subject to such stock options shall vest on the one year anniversary of your date of
hire and the remainder will vest in 36 equal monthly installments over a three year period
thereafter, subject to Executive’s continued employment or service with the Company on each such
date. Such stock options shall have a ten (10) year term and shall be subject to the terms and
conditions of the 2007 Plan and the stock option agreement pursuant to which such stock options are
granted to the extent such provisions are not less favorable to Executive than the applicable
provisions of this Agreement.

3.4 Vacation and Paid Time Off. Executive shall be entitled to 20 business days of paid vacation
each year, accruing on a monthly basis, and 8 holidays each year.

3.5 Expenses. During the term of this Agreement, the Company shall reimburse Executive for all
reasonable and necessary out-of-pocket expenses incurred by Executive in connection with services
rendered on behalf of the Company subject to Executive providing the Company with appropriate
substantiation in accordance with Company policy.

3.6 Standard Company Benefits. Executive shall be entitled to all rights and benefits for which
Executive is eligible under the terms and conditions of the standard Company benefits and
compensation practices that may be in effect from time to time and are provided by the Company to
its executive employees, employed at similar full-time or part-time status, as applicable,
generally.

4

 

ARTICLE IV

SEVERANCE AND CHANGE IN CONTROL BENEFITS

4.1 Severance Benefits. If Executive’s employment terminates due to an Involuntary Termination
Without Cause or a Covered Termination, Executive shall receive any annual base salary that has
accrued but is unpaid as of the date of such Involuntary Termination Without Cause or Covered
Termination. In addition, provided Executive first executes and does not revoke an effective
general release in the form and substance acceptable to the Company, Executive shall also be
entitled to continue to be compensated by the Company, at Executive’s annual base salary as in
effect during the last regularly scheduled payroll period immediately preceding the Involuntary
Termination Without Cause or Covered Termination, for a period of nine months, payable on the
regular payroll dates of the Company and subject to applicable tax withholding.

4.2 Acceleration of Vesting of Option. In the event of a Change In Control, Executive shall vest
in and be able to exercise the stock options held by Executive as to 50% of the unvested shares of
common stock then subject to such options. Thereafter, such options shall vest and become
exercisable as to any unvested shares of common stock subject to such options in equal monthly
installments over the 12 months following the effective date of a Change in Control; provided,
however, that in the event that fewer than 12 months remain until such options are fully vested and
exercisable, the vesting period for such options shall remain unchanged by the Change in Control.
In addition, if within the period beginning on the first day of the calendar month immediately
preceding the calendar month in which the effective date of such Change in Control occurs and
ending on the last day of the twelfth calendar month following the calendar month in which the
effective date of the Change in Control occurs, Executive’s employment with the Company (or its
successor) terminates due to an Involuntary Termination Without Cause thereof by the Company (or
any successor) or due to a Constructive Termination, then all stock options held by Executive shall
become fully vested and exercisable as of the date of such termination of Executive’s employment.

4.3 Section 409A of the Internal Revenue Code. The foregoing notwithstanding, to the extent
required to comply with Section 409A of the Code, if Executive is deemed to be a “specified
employee” for purposes of Section 409A(a)(2)(B) of the Code as of the date of termination of
employment, Executive agrees that the payments due to his/her under Section 4.1 in connection with
a termination of his/her employment that would otherwise have been payable at any time during the
six-month period immediately following such termination of employment shall not be paid prior to,
and shall instead be payable in a lump sum as soon as practicable following, the expiration of such
six-month period.

4.4 Failure to Perform. Notwithstanding any other provision of this Agreement, if Executive shall
be discharged by the Company for Cause or if Executive terminates employment other than as a result
of a Constructive Termination, then this Agreement shall automatically terminate (except for
Article V, Article VII, and Article VIII, which shall continue in effect), and upon such
termination, the Company shall have no further obligation to Executive, his/her
spouse or estate, except that the Company shall pay to Executive, the amount of his/her base salary
and vacation pay accrued to the date of such termination.

5

 

ARTICLE V

PROPRIETARY INFORMATION OBLIGATIONS

5.1 Agreement. Executive agrees to execute and abide by the Company’s standard form of Proprietary
Information and Inventions Agreement (“Proprietary Information and Inventions Agreement”).

5.2 Remedies. Executive’s duties under the Proprietary Information and Inventions Agreement shall
survive termination of Executive’s employment with the Company and the termination of this
Agreement. Executive acknowledges that a remedy at law for any breach or threatened breach by
Executive of the provisions of the Proprietary Information and Inventions Agreement would be
inadequate, and Executive therefore agrees that the Company shall be entitled to injunctive relief
in case of any such breach or threatened breach.

ARTICLE VI

OUTSIDE ACTIVITIES

6.1 Other Activities. Except with the prior written consent of the Chief Executive Officer or
President of the Company, Executive shall not during the term of this Agreement undertake or engage
in any other employment, occupation or business enterprise, other than ones in which Executive is a
passive investor; provided that such passive investments will not require services on the part
Executive which would in any manner impair the performance of his/her duties under this Agreement.
Executive may engage in civic and not-for-profit activities so long as such activities do not
materially interfere with the performance of Executive’s duties hereunder.

6.2 Competition/Investments. During the term of Executive’s employment by the Company, except on
behalf of the Company, Executive shall not directly or indirectly, whether as an officer, director,
stockholder, partner, proprietor, associate, representative, consultant, or in any capacity
whatsoever engage in, become financially interested in, be employed by or have any business
connection with any other person, corporation, firm, partnership or other entity whatsoever which
were known by Executive to compete directly with the Company, throughout the world, in any line of
business engaged in (or planned to be engaged in) by the Company.

ARTICLE VII

NONINTERFERENCE

While employed by the Company, and for one year immediately following the date on which Executive
terminates employment or otherwise ceases providing services to the Company, Executive agrees not
to interfere with the business of the Company by (i) soliciting or attempting to solicit any
employee or consultant of the Company to terminate such employee’s or consultant’s employment or
service in order to become an employee, consultant or independent contractor to or for any
competitor of the Company or (ii) soliciting or attempting to solicit any
client, customer or other person either directly or indirectly, to direct his/her or its purchase
of the Company’s products and/or services to any person, firm, corporation, institution or other
entity in competition with the business of the Company. Executive’s duties under this Article

6

 

VII shall survive termination of Executive’s employment with the Company and the termination of this
Agreement.

ARTICLE VIII

GENERAL PROVISIONS

8.1 Notices. Any notices provided hereunder must be in writing and shall be deemed effective upon
the earlier of personal delivery (including personal delivery by facsimile) or the third day after
mailing by first class mail, to the Company at its primary office location and to Executive at
Executive’s address as listed on the Company payroll.

8.2 Severability. Whenever possible, each provision of this Agreement will be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Agreement is
held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any
jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision
or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such
jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained
herein.

8.3 Waiver. If either party should waive any breach of any provisions of this Agreement, they
shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any
other provision of this Agreement.

8.4 Complete Agreement. This Agreement and the documents and agreements referenced herein
constitute the entire agreement between Executive and the Company and is the complete, final, and
exclusive embodiment of their agreement with regard to the subject matter contained herein and
therein and supersede all prior agreements, promises, covenants, arrangements, communications,
representations or warranties, whether oral or written, by any officer, employee or representative
of any party hereto, and any prior agreement of the parties hereto in respect of the subject matter
contained herein. This Agreement is entered into without reliance on any promise or representation
other than those expressly contained herein or therein, and cannot be modified or amended except in
a writing signed by an appropriate officer of the Company and Executive.

8.5 Counterparts. This Agreement may be executed in separate counterparts, any one of which need
not contain signatures of more than one party, but all of which taken together will constitute one
and the same Agreement.

8.6 Headings. The headings of the sections hereof are inserted for convenience only and shall not
be deemed to constitute a part hereof nor to affect the meaning thereof.

8.7 Successors and Assigns. This Agreement is intended to bind and inure to the benefit of and be
enforceable by Executive and the Company, and their respective successors, assigns, heirs,
executors and administrators, except that Executive may not assign any of Executive’s
duties hereunder and Executive may not assign any of Executive’s rights hereunder, without the
written consent of the Company, which shall not be withheld unreasonably.

7

 

8.8 Arbitration. Unless otherwise prohibited by law or specified below, all disputes, claims and
causes of action, in law or equity, arising from or relating to this Agreement or its enforcement,
performance, breach, or interpretation shall be resolved solely and exclusively by final and
binding arbitration held in San Diego, California through Judicial Arbitration & Mediation
Services/Endispute (“JAMS”) under the then existing JAMS arbitration rules. However, nothing in
this section is intended to prevent either party from obtaining injunctive relief in court to
prevent irreparable harm pending the conclusion of any such arbitration. Each party in any such
arbitration shall be responsible for its own attorneys’ fees, costs and necessary disbursement;
provided, however, that if one party refuses to arbitrate and the other party seeks to compel
arbitration by court order, if such other party prevails, it shall be entitled to recover
reasonable attorneys’ fees, costs and necessary disbursements. Pursuant to California Civil Code
Section 1717, each party warrants that it was represented by counsel in the negotiation and
execution of this Agreement, including the attorneys’ fees provision herein.

8.9 Attorneys’ Fees. If either party hereto brings any action to enforce rights hereunder, each
party in any such action shall be responsible for its own attorneys’ fees and costs incurred in
connection with such action.

8.10 Choice of Law. All questions concerning the construction, validity and interpretation of this
Agreement will be governed by the law of the State of California without regard to the conflicts of
law provisions thereof.

(Signature page follows)

8

 

          In Witness Whereof, the parties have executed this Agreement on the day and year
first above written.

	 	 	 	 	 
	 	OREXIGEN THERAPEUTICS, INC.

 	 
	 	By:  	 	 
	 	 	Gary D. Tollefson, M.D., Ph.D. 	 
	 	 	CEO and President 	 
	 

Accepted and agreed:

 

[Employee]

9exh10_29.htm

     Exhibit
10.29 

     

    

     

     STOCK
PURCHASE AGREEMENT 

     

     This
Stock Purchase Agreement (the “Agreement”) is made as of this 5th day of March,
2008 by and among Tri-State
Employment Services, Inc. a corporation with offices located at 160
Broadway, 15 Floor, New York, NY 10037 (the “Buyer”) and Accountabilities, Inc.,
a Delaware corporation (the “Company”) with offices located at 195 Route 9
South, Suite 109, Manalapan, New Jersey 07726. 

     

     WHEREAS,
the Buyer wishes to buy and the Company wishes to sell 1,000,000 shares of the
Company’s Common Stock; 

     

     NOW,
THEREFORE, in consideration of the mutual promises and covenants contained in
this Agreement, and for other valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the parties hereto agree as
follows: 

     

    
      	
               1.   

            	
              Purchase of
      Shares .  The Company hereby sells to the Buyer, and
      the Buyer hereby purchases from the Company, 1,000,000 shares of the
      Company’s Common Stock (the “Shares”) for an aggregate purchase price (the
      “Purchase Price”) of TWO HUNDRED THOUSAND and 00/100 DOLLARS ($200,000),
      which will be comprised of the following
  consideration: 

            

    

     

    
      	
               (a)   

            	
               FIFTY
      THREE THOUSAND FIVE HUNDRED AND TWO and 00/100 DOLLARS ($53,502) payable
      by wire transfer or certified
check 

            

    

     

    
      	
               (b)   

            	
               Conversion
      of outstanding invoices payable due from the Company to the Buyer
      amounting to TWENTY SIX THOUSAND FOUR HUNDRED AND NINETY EIGHT and 00/100
      DOLLARS ($26,498) 

            

    

     

    
      	
               (c)   

            	
               Conversion
      of the loan dated February 23, 2007 in the principal amount of $950,000
      due from the Company to the Buyer with a current outstanding principal
      amount of ONE HUNDRED AND TWENTY THOUSAND and 00/100 DOLLARS
      ($120,000) 

            

    

     

    
      	
               2.   

            	
              Representations of the
      Company .  The Company hereby represents and warrants
      to the Buyer as follows: 

            

    

     

    
      	
               (a)   

            	
               The
      Company is a corporation duly organized, validly existing and in good
      standing under the laws of the State of New
  Jersey. 

            

    

     

    
      	
               (b)   

            	
               The
      Company has the full corporate power and authority to enter into this
      Agreement and to perform its obligations
  hereunder. 

            

    

     

    
      	
               (c)   

            	
               The
      Shares of Common Stock sold and issued to the Buyer pursuant to this
      Agreement are duly authorized, validly issued and
      non-assessable. 

            

    

     

    
      	
               3.   

            	
              Representations of the
      Buyer.   The Buyer hereby represents and warrants to
      the Company as follows: 

            

    

     

    
      
          

      

      
         1 

        
          

        

      

      
          

      

    

    

     

    
      	
               (a)   

            	
               The
      Company has made available to the Buyer the opportunity to ask questions
      of, and receive answers from, the officers of the Company concerning the
      Company and its business.  The Buyer acknowledges that he/she
      has purchased the Shares without being furnished any
      prospectus. 

            

    

     

    
      	
               (b)   

            	
               The
      Shares have been acquired for investment and not with a view to the resale
      or distribution of such securities.  Such Shares are being
      acquired by the Buyer for his/her own account and with his/her own funds,
      and no other person shall have a direct or indirect beneficial interest in
      such securities. 

            

    

     

    
      	
               (c)   

            	
               The
      Buyer understands that the Company engages in a highly competitive
      business and there can be no assurance that it will be able to operate
      profitably. This investment is highly speculative investment and involves
      a high degree of risk and is not recommended for any investor who cannot
      afford the risk of losing his/her entire
  investment. 

            

    

     

    
      	
               (d)   

            	
               The
      Buyer understands that none of the Shares have been registered under the
      Securities Act of 1933, as amended (the “Securities Act”), in reliance on
      an exemption for private offerings.  Because the Company has no
      obligation to effect such registration, the Buyer may have to continue to
      bear the economic risk of their ownership of such securities for an
      indefinite period; and Buyer will not be permitted to transfer any of such
      securities in the absence of an opinion of counsel, if requested,
      satisfactory to the Company that registration is not required under the
      Securities Act and under applicable state securities
    laws. 

            

    

     

    
      	
               4.   

            	
              Governing
      Law.   This Agreement and its validity, construction
      and performance shall be governed in all respects by the laws of the State
      of Delaware, without giving effect to principles of conflict of
      laws. 

            

    

     

    
      	
               5.   

            	
              Severability.   If
      any provisions of this Agreement or the application of any provision
      hereof to any person or circumstance is held invalid, the remainder of
      this Agreement and the application of such provision to other persons or
      circumstances shall not be affected unless the provision held invalid
      shall substantially impair the benefits of the remaining portions of this
      Agreement. 

            

    

     

    
      	
               6.   

            	
              Benefit of Parties,
      Assignment.   This Agreement shall be binding upon and
      inure to the benefit of the parties hereto and their respective personal
      representatives, heirs, successors and assigns.  This Agreement
      may not be assigned by any party hereto except with the prior written
      consent of the other party
hereto. 

            

    

     

    
      	
               7.   

            	
              Headings.   The
      headings in the sections of this Agreement are inserted for convenience of
      reference only and shall not constitute a part
  hereof. 

            

    

     

    
      	
               8.   

            	
              Construction.   As
      used in this Agreement, words in the singular shall be construed as
      including the plural and vice versa and words in one gender shall include
      all genders unless the context shall clearly require
      otherwise. 

            

    

     

    
      
          

      

      
         2 

        
          

        

      

      
          

      

    

    

     

    
      	
               9.   

            	
              Counterparts.   This
      Agreement may be executed in one or more counterparts, each of which shall
      be an original, but all of which together shall constitute one and the
      same instrument. 

            

    

     

     IN
WITNESS WHEREOF, the parties hereto have executed this Agreement to be executed
as of the day and year first above written. 

     

    
      
        	  Tri-State
      Employment Services, Inc. 	   	   	  ACCOUNTABILITIES,
      INC. 	   
	
                 /s/
      John Messina 

              	   	   	
                 /s/
      Stephen DelVecchia 

              	   
	
                 Name: 
      John Messina 

              	   	   	
                 Name: 
      Stephen DelVecchia  

              	   
	
                 Title: 
      Executive Vice President  

              	   	   	
                 Title: 
      Chief Financial Officer 

              	   

      

    

     

     

      3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]